Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is for subjects with adenocarcinoma of the pancreas. The purpose of this research
study is to determine the safety and effectiveness of modified Folfirinox and radiation
therapy as treatment for adenocarcinoma (cancer) of the pancreas before surgery. Screening
tests will be done to determine if subjects are eligible for participation in this study. If
subjects are eligible to participate and agree to participate they will begin chemotherapy.
After 3 cycles of chemotherapy, subjects will begin chemoradiation. Within 4 to 8 weeks of
completing radiation therapy, subjects will have surgery. There will also be post-treatment
and follow-up evaluations. Subjects will be followed for every 3 months for 3 years after
their initial registration.